- Network Sponsorships
- Grand Challenges
- Thought Leadership
- Log in
Beyond curing age-related diseases, there is a new class of interventions to address the mechanisms of aging itself: maintenance. Like regular dental cleanings on a cellular level, these treatments promise to effectively pause and even undo the natural damage we experience as side effects of being alive — and it’s happening much sooner than most people realize.
Thanks to Aubrey de Grey and the SENS Research Foundation’s work at Yale, Oxford, and around the world, basic research has exploded in the last ten years and has already led to spinoff companies. This has put future research addressing all the mechanisms of aging on a predictable timeline — meaning the first people to live well past 120 in peak health are very probably alive today.
It is essential to understand this next leap forward in human history that will define the next 20-30 years.
* What are the investment opportunities in this space?
* How can we ensure these therapies benefit everyone, rather than exacerbating the inequalities of the present?
* How can we accelerate basic research to benefit more people sooner?
* How can we keep ourselves alive long enough to benefit from these therapies?
GET TICKETS HERE!
Location: Leslie eLab, 16 Washington Place, New York, NY 10003
THANKS TO OUR SPONSOR THE WYLDE!!
SENS Research Foundation
Chief Science Officer
Aubrey de Grey is an author, biomedical gerontologist and mathematician who has made a significant contribution to the Hadwiger–Nelson problem. He is currently the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics, Inc.He is editor-in-chief of the academic journal Rejuvenation Research, author of The Mitochondrial Free Radical Theory …
Aubrey de Grey is an author, biomedical gerontologist and mathematician who has made a significant contribution to the Hadwiger–Nelson problem. He is currently the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics, Inc.He is editor-in-chief of the academic journal Rejuvenation Research, author of The Mitochondrial Free Radical Theory of Aging (1999) and co-author of Ending Aging (2007). He is known for his view that medical technology may enable human beings alive today not to die from age related causes.
De Grey is an international adjunct professor of the Moscow Institute of Physics and Technology, a fellow of the Gerontological Society of America, the American Aging Association, and the Institute for Ethics and Emerging Technologies. He has been interviewed in recent years in a number of news sources, including CBS 60 Minutes, the BBC, The New York Times, Fortune Magazine, The Washington Post, TED, Popular Science, The Colbert Report, Time and the Skeptics' Guide to the Universe. He is also a member of Flooved advisory board.
Disclaimers: By registering for, or attending, this event, you are agreeing to the following: Photographs may be taken at the event and appear on social media. You are authorizing Aging2.0 to use your image, likeness and / or name on social media such as Facebook, Twitter, the Aging2.0 blog or other marketing materials in connection with the event. The organizers of this event, Aging2.0, and any of their employees, volunteers, members and representatives are not responsible for any injury, loss or damage of any kind sustained by any person while participating in this event.